Footvax Emulsion for Injection for Sheep

देश: आयरलैंड

भाषा: अंग्रेज़ी

स्रोत: HPRA (Health Products Regulatory Authority)

इसे खरीदें

उत्पाद विशेषताएं (SPC)

19-08-2021

DSU (DSU)

18-01-2023

इस उत्पाद के लिए कुछ दस्तावेज़ वर्तमान में उपलब्ध नहीं हैं, आप हमारी ग्राहक सेवा को अनुरोध भेज सकते हैं और जैसे ही हम उन्हें प्राप्त करने में सक्षम होंगे, हम आपको सूचित करेंगे।
अनुरोध भेजा।

सक्रिय संघटक:

Dichelobacter nodosus serotype I; Dichelobacter nodosus serotype H; Dichelobacter nodosus serotype G; Dichelobacter nodosusserotype F ; Dichelobacter nodosus serotype E; Dichelobacter nodosus serotype D ; Dichelobacter nodosus serotype C ; Dichelobacter nodosus serotype B2; Dichelobacter nodosus serotype B1; Dichelobacter nodosus serotype A

थमां उपलब्ध:

Intervet Ireland Limited

ए.टी.सी कोड:

QI04AB03

INN (इंटरनेशनल नाम):

डोज़:

फार्मास्यूटिकल फॉर्म:

Emulsion for injection

प्रिस्क्रिप्शन प्रकार:

POM: Prescription Only Medicine as defined in relevant national legislation

चिकित्सीय समूह:

Sheep

चिकित्सीय क्षेत्र:

bacteroides

चिकित्सीय संकेत:

Immunological - Inactivated vaccine

प्राधिकरण का दर्जा:

Authorised

प्राधिकरण की तारीख:

2004-02-20

उत्पाद विशेषताएं

Health Products Regulatory Authority
18 August 2021
CRN00C9YH
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Footvax Emulsion for Injection for Sheep
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 1 ml dose contains:
ACTIVE SUBSTANCES:
_Dichelobacter nodosus _serotype A
10 μg pili equivalent to ≥400 potency units
*
_Dichelobacter nodosus _serotype B
1
10 μg pili equivalent to ≥400 potency units
*
_Dichelobacter nodosus _serotype B
2
10 μg pili equivalent to ≥400 potency units
*
_Dichelobacter nodosus _serotype C
10 μg pili equivalent to ≥400 potency units
*
_Dichelobacter nodosus _serotype D
10 μg pili equivalent to ≥400 potency units
*
_Dichelobacter nodosus _serotype E
10 μg pili equivalent to ≥400 potency units
*
_Dichelobacter nodosus _serotype F
10 μg pili equivalent to ≥400 potency units
*
_Dichelobacter nodosus _serotype G
10 μg pili equivalent to ≥400 potency units
*
_Dichelobacter nodosus _serotype H
10 μg pili equivalent to ≥400 potency units
*
_Dichelobacter nodosus _serotype I
5 x 10
8
cells/ml equivalent to ≥ 400 potency units
*
*
based on the potency test

ADJUVANTS:
Light mineral oil
60.0 % v/v
Mannide oleate
4.5 % v/v

EXCIPIENTS:
Preservative: thiomersal
0.015 % w/v
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Emulsion for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep from 4 weeks of age.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunisation of sheep against footrot caused by
_Dichelobacter nodosus_ for the purposes of reducing the risk of
a clinical infection due to _Dichelobacter nodosus. _
Onset of immunity: 3 weeks after the primary vaccination course.
Duration of immunity: 6 months.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Vaccinate healthy animals only.
Do not vaccinate sheep within 6 - 8 weeks of shearing.
Health Products Regulatory Authority
18 August 2021
CRN00C9YH
Page 2 of 4
Sheep destined for show or s

पूरा दस्तावेज़ पढ़ें